Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Anesthesiology. 2016 Mar;124(3):651–663. doi: 10.1097/ALN.0000000000000992

Figure 13.

Figure 13

Relationship between in vitro γ-aminobutyric acid type A (GABAA) receptor and in vivo hypnotic potencies of etomidate and etomidate analogues. Each compound’s GABAA receptor potency is defined as the half-maximal direct activating concentration (EC50) and its hypnotic potency is defined as the median effective dose that produces loss of righting reflexes in rats (ED50). The dashed line is a linear fit of the logarithm-transformed data. The slope of the fitted line was 1.22 ± 0.18 and the coefficient of determination (r2) was 0.72.